跳至主要内容
临床试验/NL-OMON41755
NL-OMON41755已完成不适用

Technical validation of quantitative methods for 3 'deoxy-3-[18F] fluorothymidine ([18F] FLT) PET in liver metastases of colorectal cancer patients - FLT PET Liver

Academisch Medisch Centrum0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational invasive

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patient age 18 years or older
  • Histological diagnosis of mCRC (stage IV) without options for localregional treatment
  • Presence of liver metastases on CT scan
  • Presence of at least one liver metastases of >20mm in diameter on the CT scan
  • Upper part of liver with left heart ventricle in field of view
  • Able to remain supine for 90 minutes in the PET-CT scanner
  • Ability to give study specific written informed consent

排除标准

  • Pregnant or lactating patients (positive pregnancy test)
  • Metal implants (eg pacemakers)
  • Body weight > 100 kg
  • Severe claustrophobia
  • Receiving chemotherapy less than 2 months prior to the first PET scan, except in the case of progression under chemotherapy than a 2 week interval is required.

研究者

相似试验